You're offering supervised, in-person GLP-1 care. Patients in Belleville and O'Fallon want exactly that. So why are they booking through an app?
A patient in O'Fallon opens Google and types "GLP-1 near me." They want a real doctor. They want someone who knows their chart, not a telehealth app that mails them a syringe in a box. They'd rather drive ten minutes to a clinic in Fairview Heights than fill out an intake form at 11pm for some company incorporated in Delaware.
But when they search, they don't find you. They find Hims. They find WeightWatchers. They find three national telehealth platforms with eight-figure ad budgets and content teams that publish four articles a week. Your clinic — which offers better care, more accountability, and a real human prescriber — is on page three.
That's the GLP-1 content gap. And it's costing local practices patients every single day.
The GLP-1 market crossed $24 billion in 2025. Over 30 million Americans are now on these medications. Demand hasn't peaked — it's still accelerating. And here's the part that matters for your practice: search volume for "GLP-1" has now surpassed search volume for the brand names themselves. People aren't Googling "Ozempic" as often. They're searching for the drug class, for local providers, for comparisons between telehealth and in-person care.
That shift should be an opening for local medical weight loss clinics. But most of them haven't updated their websites in two years, have no blog content, and aren't ranking for any GLP-1 related search terms in their own city.
The practices that publish clear, educational content about their GLP-1 programs win patient trust before the first phone call. The ones that don't are invisible — regardless of how good their care actually is.
Meanwhile, the telehealth platforms are pouring money into content. They're publishing comparison guides, FAQ pages, "what to expect on GLP-1" series, location-specific landing pages. They have entire content teams doing what most independent clinics haven't even started.
When someone in Edwardsville or Collinsville decides they want to look into GLP-1 therapy, they don't book the first thing they find. They research. They compare. According to 2025 data, 77% of patients search online before booking any health appointment — and for a program that costs $300 to $500 a month, the research phase is longer and more careful than a routine checkup.
They're asking questions like:
If your website answers none of these questions, a patient who would have chosen you — because you're local, because you're credentialed, because you offer real supervision — ends up booking through a telehealth app instead. Not because the app is better. Because the app had the answers and you didn't.
Here's something worth sitting with: in March 2026, the FDA issued warning letters to 30 telehealth companies making false or misleading claims about compounded GLP-1 products. Thousands of similar warnings have gone out since late 2025. Patients are starting to hear about this. They're reading about it. Some of them are nervous about the telehealth route precisely because of the regulatory turbulence around compounded semaglutide.
That nervousness is a door for in-person providers.
A patient who's read three articles about shady compounders and FDA warnings is primed to want a local physician they can actually sit across from. But that desire only converts to a booking if they can find you — and if your website explains, plainly, what makes your program different from the apps.
Most clinic websites don't do that. They have a page that says "medical weight loss" and lists semaglutide as one of several services, buried under the sixth menu item. There's no educational content, no FAQ, no honest comparison between in-clinic and telehealth care.
Let me be specific about what's missing, because "you need more content" is too vague to be useful.
Most medical weight loss clinic websites in Metro East Illinois are missing all of the following:
A dedicated GLP-1 service page — not a paragraph on the general services page, but a full page that explains the program, addresses common concerns, and tells a patient exactly what to expect from their first appointment to their third month on treatment.
FAQ content targeting real patient questions — the questions above, plus local variations. "Is there a GLP-1 program in Belleville" should surface your clinic. If nobody has written a page answering that, nobody is going to rank for it.
Blog posts that address the research phase — comparison articles, what-to-expect guides, honest takes on side effects. Not promotional copy. Actual useful information that a patient doing their homework would find valuable.
Local signals throughout the site — mentioning Edwardsville, O'Fallon, Shiloh, Troy. Patients searching locally will see your content and recognize you're actually in their area, not a national platform with a local phone number.
There's a meaningful difference between a telehealth app and a physician who knows your chart. The problem is that difference is invisible online if you haven't written about it.
Physicians and clinic owners are not content strategists. That's not a criticism — it's obvious. You went to school for medicine, not marketing. The question of what to write about, how often, and how to structure it for Google is genuinely unfamiliar territory for most practices.
And even if you know content marketing matters, the time problem is real. A GLP-1 program is not a passive service. Patients need monitoring, dose adjustments, labs, check-ins. You're already at capacity with patient care. Writing blog posts about semaglutide at 9pm on a Tuesday is not a sustainable content strategy. We get into this tradeoff in more depth in our piece on done-for-you vs. DIY marketing — it's worth a read if the time question resonates.
So nothing gets written. The website stays static. The telehealth platforms keep publishing. The gap widens.
There's also a genuine confusion about what to publish. Regulatory-wise, medical marketing has guardrails. Practices sometimes overcorrect and publish nothing, worried about running afoul of FTC rules about before/after claims or outcome promises. That caution is understandable — but it's led some practices to believe they can't publish anything useful, which isn't true. Educational content about how GLP-1 medications work, what a supervised program involves, and how in-person care differs from telehealth is entirely publishable. It's the unsubstantiated outcome claims that are the problem.
For a medical weight loss clinic in Metro East Illinois, a realistic content plan looks something like this:
A dedicated GLP-1 program page with a real explanation of your protocol — not boilerplate. A few foundational blog posts: what patients should know before starting semaglutide, how your program compares to telehealth options, what to expect in the first 90 days. A local landing page targeting searches specific to your city — "medical weight loss Belleville IL" or "GLP-1 program Edwardsville."
None of this is technically complicated. It's time-consuming. It requires someone who understands both how to write for search and how to speak to a patient who's skeptical and doing their homework. But the opportunity is real — because your competitors in the telehealth space have the budget but not the local credibility, and your competitors in the local space largely haven't started yet.
That window closes as more local clinics wake up to this. The practices that build their content foundation now will own the local GLP-1 search terms in their cities for years.
If you want to understand what this looks like specifically for your practice, take a look at our medical weight loss marketing page — or reach out directly and we can walk through your current site together.
We handle the content — service pages, blog posts, local SEO — so you can focus on the practice. No contracts, no surprises.
Talk to Kerry